Vycor Medical Q1 revenue up 30% to $436k; operating profit turns positive

VYCOR MEDICAL INC

2025-Q1 EPS reported -$0.01 revenue$436,378

Revenue of $436,378 (+30% YoY); Vycor Medical division revenue $418,520 (+31%).
Non-GAAP cash operating profit of $21,619 vs $8,452 in prior year.
Gross margin 82% (down from 89%) due to validation, shipping costs and sales mix.
New distribution agreements signed for France and Spain; three VBAS clinical papers published.
NovaVision division revenue $17,858 (-3% YoY), remains in development stage.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.